ProShare Advisors LLC - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
ProShare Advisors LLC ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$36,998
-55.3%
17,452
+0.4%
0.00%
Q2 2023$82,771
-12.5%
17,389
+4.8%
0.00%
Q1 2023$94,557
-53.1%
16,589
-17.0%
0.00%
-100.0%
Q4 2022$201,628
-51.8%
19,983
+7.2%
0.00%
-50.0%
Q3 2022$418,000
-7.1%
18,636
+2.3%
0.00%
+100.0%
Q2 2022$450,000
-57.1%
18,209
-32.7%
0.00%
-50.0%
Q1 2022$1,049,000
-46.0%
27,053
-18.5%
0.00%
-50.0%
Q4 2021$1,943,000
+0.4%
33,208
+1.7%
0.00%
-20.0%
Q3 2021$1,935,000
-40.8%
32,646
-13.3%
0.01%
-50.0%
Q2 2021$3,269,000
+19.0%
37,662
+13.1%
0.01%
+11.1%
Q1 2021$2,746,000
+3.0%
33,302
+13.5%
0.01%
-10.0%
Q4 2020$2,667,000
+193.1%
29,333
+28.8%
0.01%
+150.0%
Q3 2020$910,000
+26.7%
22,774
+8.8%
0.00%0.0%
Q2 2020$718,000
+131.6%
20,928
+50.0%
0.00%
+100.0%
Q1 2020$310,000
-35.6%
13,954
-43.2%
0.00%0.0%
Q4 2019$481,000
+31.1%
24,569
+4.0%
0.00%0.0%
Q3 2019$367,000
-29.0%
23,627
-7.2%
0.00%
-33.3%
Q2 2019$517,000
+3.2%
25,449
-10.7%
0.00%0.0%
Q1 2019$501,000
+38.0%
28,513
+0.9%
0.00%0.0%
Q4 2018$363,00028,2700.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders